Histopathological assays and surveys of cancer cell lines further confirmed PRSS23 expression was significantly increased in ERα-positive breast cancers, and PRSS23 expression was upregulated by ERα-mediated transcriptional regulation. The gene discussed is PRSS23; the disease is breast carcinoma.